HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carol A Sartorius Selected Research

Hormones (Hormone)

3/2022Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism.
1/2022Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer.
12/2021Advances in Analyzing the Breast Cancer Lipidome and Its Relevance to Disease Progression and Treatment.
1/2021Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer.
1/2021Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity.
1/202090 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future.
1/2017Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts.
6/2015Steroid hormones, steroid receptors, and breast cancer stem cells.
10/2012A high-content assay to identify small-molecule modulators of a cancer stem cell population in luminal breast cancer.
9/2012Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carol A Sartorius Research Topics

Disease

42Breast Neoplasms (Breast Cancer)
03/2022 - 06/2003
41Neoplasms (Cancer)
03/2022 - 06/2003
6Neoplasm Metastasis (Metastasis)
01/2022 - 09/2006
4Carcinogenesis
01/2020 - 07/2003
3Lymphatic Metastasis
11/2010 - 11/2007
2Triple Negative Breast Neoplasms
01/2017 - 05/2015
2Ovarian Neoplasms (Ovarian Cancer)
11/2015 - 11/2010
2Ovarian Epithelial Carcinoma
11/2015 - 11/2010
2Tics (Tic)
07/2012 - 07/2011
1Hypersensitivity (Allergy)
01/2021
1Thyroid Diseases (Thyroid Disease)
01/2021
1Hypertrophy
01/2018
1Obesity
01/2018
1Weight Gain
01/2018
1Endometrial Neoplasms (Endometrial Cancer)
03/2016
1Epilepsy (Aura)
05/2015
1Disease Progression
09/2012
1Testicular Neoplasms (Testicular Cancer)
09/2012

Drug/Important Bio-Agent (IBA)

22Estrogen ReceptorsIBA
03/2022 - 07/2003
19Estrogens (Estrogen)FDA Link
03/2022 - 06/2003
17Progesterone Receptors (Progesterone Receptor)IBA
03/2022 - 06/2003
12Hormones (Hormone)IBA
03/2022 - 09/2006
12ProgesteroneFDA LinkGeneric
01/2021 - 07/2003
11Progestins (Progestagens)IBA
03/2022 - 11/2005
11Phenobarbital (Luminal)FDA Link
01/2021 - 11/2005
9TamoxifenFDA LinkGeneric
01/2021 - 06/2003
7RNA (Ribonucleic Acid)IBA
03/2022 - 01/2008
6Steroid Receptors (Steroid Receptor)IBA
01/2021 - 04/2008
5Keratin-5 (Keratin 5)IBA
01/2020 - 07/2011
5Estradiol (Delestrogen)FDA LinkGeneric
11/2016 - 07/2003
4Estrogen Receptor alphaIBA
01/2022 - 11/2016
4LigandsIBA
01/2022 - 06/2003
4SteroidsIBA
01/2021 - 01/2010
4Androgen Receptors (Androgen Receptor)IBA
01/2021 - 09/2012
4Keratins (Keratin)IBA
11/2015 - 04/2008
3Progesterone CongenersIBA
01/2020 - 06/2015
3Pharmaceutical PreparationsIBA
01/2019 - 01/2014
2Transcription Factors (Transcription Factor)IBA
01/2020 - 01/2020
2Fulvestrant (Faslodex)FDA Link
01/2020 - 11/2016
2Phosphotransferases (Kinase)IBA
01/2017 - 07/2012
2AndrogensIBA
11/2016 - 06/2015
2LuciferasesIBA
02/2013 - 10/2012
2Protein Isoforms (Isoforms)IBA
07/2003 - 06/2003
1Fatty Acids (Saturated Fatty Acids)IBA
03/2022
1Aromatase InhibitorsIBA
01/2022
1exemestane (Aromasin)FDA Link
01/2022
1Epidermal Growth Factor (EGF)IBA
12/2021
1LipidsIBA
12/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Immunomodulating AgentsIBA
01/2021
1Insulin (Novolin)FDA Link
01/2021
1Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
01/2021
1Thyroid HormonesIBA
01/2021
1Mifepristone (RU 486)FDA Link
01/2021
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2021
1Insulin Receptor Substrate ProteinsIBA
01/2021
1Small Cytoplasmic RNAIBA
10/2020
1SuspensionsIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Cadherins (E-Cadherin)IBA
01/2020
1CateninsIBA
01/2020
1Cell Adhesion MoleculesIBA
01/2020
1Estrogen Receptor Modulators (Antiestrogen)IBA
01/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018
1Aromatase (CYP19)IBA
01/2018
1Fibroblast Growth Factor 1 (FGF-1)IBA
01/2018
1A-factor (Streptomyces)IBA
04/2017
1Conditioned Culture MediaIBA
04/2017
1ENMD 2076IBA
01/2017
1RNA Polymerase IIIIBA
01/2017
1Cre recombinaseIBA
12/2016
1Tumor Viral Antigens (Large T Antigen)IBA
12/2016
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
12/2016
1Glucose (Dextrose)FDA LinkGeneric
12/2016
1Complement System Proteins (Complement)IBA
12/2016
1enzalutamideIBA
11/2016
1Cisplatin (Platino)FDA LinkGeneric
11/2015
1MLN 8237IBA
05/2015
1Aurora Kinase AIBA
05/2015
1Green Fluorescent ProteinsIBA
10/2012
1AntigensIBA
09/2012
1Transforming Growth Factor beta (TGF-beta)IBA
07/2012
1Mitogen-Activated Protein KinasesIBA
07/2012
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2012
1AZD 6244IBA
07/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2012
1U 0126 (UO 126)IBA
07/2012
1Selective Estrogen Receptor Modulators (SERM)IBA
11/2010
1Protein Kinases (Protein Kinase)IBA
01/2008
1Bromodeoxyuridine (BrdU)IBA
09/2006

Therapy/Procedure

21Therapeutics
01/2022 - 07/2003
4Drug Therapy (Chemotherapy)
11/2015 - 07/2011
3Lasers (Laser)
11/2010 - 11/2007
1Duration of Therapy
01/2021
1Immunotherapy
01/2021
1Ovariectomy (Oophorectomy)
01/2020
1Intravenous Injections
01/2019
1Aftercare (After-Treatment)
01/2017
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
09/2008
1Replantation
04/2008